| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Biology (H.S., X.-Y.Z., S.-Y.C.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4264; Department of Human Genetics (D.F.), Mount Sinai School of Medicine, New York, New York 10029; and Department of Pathology (M.C.W.), Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Address all correspondence and requests for reprints to: Dr. S.-Y. Cheng, Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Drive, Room 5128, Bethesda, Maryland 20892-4264. E-mail: sycheng{at}helix.nih.gov.
Mutations in the thyroid hormone receptor (TR) ß gene result in resistance to thyroid hormone (RTH), characterized by reduced sensitivity of tissues to thyroid hormone. To understand which physiological TR pathways are affected by mutant receptors, we crossed mice with a dominantly negative TRß mutation (TRßPV) with mice carrying a TRß null mutation (TRß-/-) to determine the consequences of the TRßPV mutation in the absence of wild-type TRß. TRßPV/- mice are distinct from TRß+/- mice that did not show abnormalities in thyroid function tests. TRßPV/- mice are also distinct from TRßPV/+ and TRß-/- mice in that the latter shows mild dysfunction in the pituitary-thyroid axis, whereas the former exhibit very severe abnormalities, including extensive papillary hyperplasia of the thyroid epithelium, indistinguishable from that observed in TRßPV/PV mice. Similar to TRßPV/PV mice, TRßPV/- mice exhibited impairment in weight gain. Moreover, the abnormal regulation patterns of T3-target genes in the tissues of TRßPV/- and TRßPV/PV mice were strikingly similar. Using TR isoforms and PV-specific antibodies in gel shift assays, we found that in vivo, PV competed with TR
1 for binding to thyroid hormone response elements in TRßPV/- mice as effectively as in TRßPV/PV mice. Thus, the actions of mutant TRß are markedly potentiated by the ablation of the second TRß allele, suggesting that interference with wild-type TR
1-mediated gene regulation by mutant TRß leads to severe RTH.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
P.-J. Tai, Y.-H. Huang, C.-H. Shih, R.-N. Chen, C.-D. Chen, W.-J. Chen, C.-S. Wang, and K.-H. Lin Direct Regulation of Androgen Receptor-Associated Protein 70 by Thyroid Hormone and Its Receptors Endocrinology, July 1, 2007; 148(7): 3485 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Genetically Modified Animals in Endocrinology Endocr. Rev., December 1, 2005; 26(7): 985 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ying, F. Furuya, M. C. Willingham, J. Xu, B. W. O'Malley, and S.-y. Cheng Dual Functions of the Steroid Hormone Receptor Coactivator 3 in Modulating Resistance to Thyroid Hormone Mol. Cell. Biol., September 1, 2005; 25(17): 7687 - 7695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kato, H. Ying, M. C. Willingham, and S.-Y. Cheng A Tumor Suppressor Role for Thyroid Hormone {beta} Receptor in a Mouse Model of Thyroid Carcinogenesis Endocrinology, October 1, 2004; 145(10): 4430 - 4438. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Dupre, H. Guissouma, F. Flamant, I. Seugnet, T. S. Scanlan, J. D. Baxter, J. Samarut, B. A. Demeneix, and N. Becker Both Thyroid Hormone Receptor (TR){beta}1 and TR{beta}2 Isoforms Contribute to the Regulation of Hypothalamic Thyrotropin-Releasing Hormone Endocrinology, May 1, 2004; 145(5): 2337 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki and S.-y. Cheng Compensatory Role of Thyroid Hormone Receptor (TR){alpha}1 in Resistance to Thyroid Hormone: Study in Mice with a Targeted Mutation in the TR{beta} Gene and Deficient in TR{alpha}1 Mol. Endocrinol., August 1, 2003; 17(8): 1647 - 1655. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |